Journal of Cancer Genetics and Biomarkers
JCGB welcomes manuscripts that make a clear genetic, genomic, molecular, or biomarker contribution to cancer research. General submissions are welcome on a rolling basis.
The scientific contribution should connect cancer research to a meaningful genetic, genomic, molecular, or biomarker dimension.
Mechanism
Studies that clarify genetic, genomic, epigenetic, or molecular mechanisms relevant to cancer.
Evidence
Discovery, analytical evaluation, or validation work with methods and evidence proportionate to the claim.
Translation
Clinical or translational studies when the molecular, genomic, or biomarker component is central rather than incidental.
Use the journal’s own requirements and policies rather than a generic campaign checklist or a promise of an outcome.
Scope
Explain the study question, methods, evidence, and the limits of the conclusions. Clinical management work without a substantive molecular, genetic, genomic, or biomarker element is not the intended fit.
Integrity
Prepare the declarations and supporting information required by the Author Instructions and Editorial Policies, including ethical, funding, competing-interest, and data-availability information where applicable.
Route
Submit through ManuscriptZone. Do not rely on a “quick” form, email shortcut, or an unlisted special-issue label.
JCGB lists a special issue only after its scope, editorial leadership, and schedule have been verified. See Special Issues for the current status; do not assign an unannounced special-issue label to a manuscript.
Read the author requirements, then use ManuscriptZone to submit one complete manuscript record.